高级检索

恶性肿瘤终末期患者贫血状态的调查

Investigation of anemia in patients with terminal malignant tumors

  • 摘要: 目的:分析恶性肿瘤终末期患者贫血的发生率和严重程度,为改进恶性肿瘤患者的支持治疗提供参考。方法:调查2004年1月至2014年12月复旦大学附属中山医院确诊的恶性肿瘤患者,对患者死亡前1年的血常规进行分析,比较死亡前12个月、9个月、6个月、3个月、1个月内发生贫血的比例、重度贫血发生的比例及Hb的平均水平。结果:恶性肿瘤患者在死亡前12个月、9个月、6个月、3个月及1个月内发生贫血比例分别为79.79%、82.23%、82.77%、90.34%及95.33%,各时点间差异均有统计学意义(P=0.000);重度贫血患者比例在各时点分别为5.67%、3.05%、6.72%、9.66%、18.00%,各时点间差异亦有统计学意义(P=0.000)。恶性肿瘤患者死亡前的平均Hb水平随病程逐渐降低,前述各时点平均Hb水平差异有统计学意义(P=0.000)。患者死亡前1个月内和3个月的平均Hb水平显著低于死亡前6个月前各时点(P=0.000);患者死亡前1个月内平均Hb水平低于死亡前3个月(P=0.000);患者死亡前6个月、9个月及12个月间平均Hb水平差异无统计学意义。结论:死亡前1年恶性肿瘤患者贫血比例随病情接近死亡终点而显著增加,需要输血的重度贫血患者比例亦显著增加;恶性肿瘤患者死亡前3个月,贫血程度明显加重;对肿瘤患者终末期进行贫血检测及加强支持治疗十分重要。

     

    Abstract: Objective:To analyze the incidence and severity of anemia in patients with terminal malignant tumors (MT), for the purpose of providing reference for improving the supportive treatment of patients with malignant tumor. Methods:A total of 2 037 patients diagnosed with MT in Zhongshan Hospital, Fudan University from 2004 to 2014 were included, and blood routine examinations of the patients during their last year of life-span were evaluated. The proportion of anemia and severe anemia, and the average level of hemoglobin of the patients within the last 12 months, 9 months, 6 months, 3 months, and 1 month of their life. Results:The proportions of anemia in patients with terminal MT within the last 12 months, 9 months, 6 months, 3 months, and 1 month of their life were 79.79%, 82.23%, 82.77%, 90.34%, and 95.33%, with significant differences among different time points (P=0.000), and the proportions of severe anemia were 5.67%,3.05%,6.72%,9.66%, and 18.00%, correspondingly, with significant differences among different time points (P=0.000). The average levels of hemoglobin during the last year of the patients’ life decreased significantly as the disease progressed, also with significant differences among different time points (P=0.000). The average hemoglobin level in the first month and the third month before the death of the patient was significantly lower than that at each time point 6 months before the death (P=0.000). The average hemoglobin level in the first month before death was lower than that in the third month before death (P=0.000). There was no significant difference in the average hemoglobin level among 6 months, 9 months and 12 months before the death of the patient. Conclusions:The proportion of anemia and severe anemia requiring blood transfusion in patients with terminal MT increased during the last year of their life as death approaching. The degree of anemia was significantly increased 3 months before the death of the patients with terminal MT. For these patients, anemia examination and enhanced support treatment is of great importance.

     

/

返回文章
返回